Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
St. Jude Children's Research Hospital
University of Washington
Merck Sharp & Dohme LLC
University College, London
City of Hope Medical Center
Fred Hutchinson Cancer Center
The Affiliated People's Hospital of Ningbo University
Hospital General de Mexico
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
First Affiliated Hospital of Zhejiang University